Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-20-005803
Filing Date
2020-03-20
Accepted
2020-03-20 20:28:55
Documents
1
Period of Report
2019-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rdgdoc.html 4/A  
1 FORM 4/A rdgdoc.xml 4/A 4466
  Complete submission text file 0001437749-20-005803.txt   5825
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Issuer) CIK: 0001595248 (see all company filings)

EIN.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17406 PAVAROSO STREET BOCA RATON FL 33496
Business Address
Friedman David E. (Reporting) CIK: 0001735757 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38244 | Film No.: 20733381